Currently out of the existing stock ratings of Laura Sutcliffe, 19 are a BUY (39.58%), 29 are a HOLD (60.42%).

Laura Sutcliffe

Work Performance Price Targets & Ratings Chart

Analyst Laura Sutcliffe works at UBS with a stock forecast success ratio of 31.44% fulfilled within 120.17 days on average.

Laura Sutcliffe’s has documented 95 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RMD, ResMed at 25-Jan-2024.

Wall Street Analyst Laura Sutcliffe

Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.

Average potential price target upside

GLPG Galapagos NV ADR GSK GlaxoSmithKline PLC ADR NVS Novartis AG ADR GMAB Genmab AS SNY Sanofi ADR UCBJY UCB SA ADR RMD ResMed

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

31

$-0.86 (-2.70%)

41

20 days ago

5/9 (55.56%)

$-1.48 (-4.56%)

14

Hold

38

$6.14 (19.27%)

37

1 months 14 days ago

11/14 (78.57%)

$3.54 (10.27%)

22

Hold

44.45

$12.59 (39.52%)

73.23

7 months 28 days ago

0/2 (0%)

$7.09 (18.98%)

Hold

38

$6.14 (19.27%)

41

8 months 14 days ago

11/13 (84.62%)

$-2.43 (-6.01%)

23

40

$8.14 (25.55%)

42

8 months 17 days ago

10/22 (45.45%)

$-2.36 (-5.57%)

73

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Laura Sutcliffe is most bullish on?

Potential upside of $-7.76 has been obtained for RMD (RESMED)

What Year was the first public recommendation made by Laura Sutcliffe?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?